We are live on ! Find out more
WST icon

West Pharmaceutical
WST

324 hedge funds and large institutions have $6.86B invested in West Pharmaceutical in 2018 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 102 increasing their positions, 118 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

10% more capital invested

Capital invested by funds: $6.23B → $6.86B (+$635M)

8% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 36

0% more funds holding

Funds holding: 323 → 324 (+1)

1.28% less ownership

Funds ownership: 95.39% → 94.11% (-1.3%)

14% less repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 118

14% less call options, than puts

Call options by funds: $1.7M | Put options by funds: $1.98M

Holders
324
Holders Change
+1
Holders Change %
+0.31%
% of All Funds
7.42%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
39
Increased
102
Reduced
118
Closed
36
Calls
$1.7M
Puts
$1.98M
Net Calls
-$278K
Net Calls Change
-$278K

Top Buyers

1
Bessemer Group
Bessemer Group
New Jersey
+$86.9M
2
Franklin Resources
Franklin Resources
California
+$75.1M
3
CIP
Champlain Investment Partners
Vermont
+$44.6M
4
William Blair Investment Management
William Blair Investment Management
Illinois
+$29.3M
5
UIM
USS Investment Management
United Kingdom
+$19.8M

Top Sellers

1
Select Equity Group
Select Equity Group
New York
-$149M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$44.8M
3
EVM
Eaton Vance Management
Massachusetts
-$29.8M
4
Invesco
Invesco
Georgia
-$28.2M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$19.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIL
351
AGF Investments LLC
Ontario, Canada
– -$36K -414 Closed
MAM
352
Meeder Asset Management
Ohio
– -$34K -380 Closed
GT
353
Greenleaf Trust
Michigan
– -$31K -349 Closed
APP
354
Avantax Planning Partners
Iowa
– -$14K -171 Closed
WCM
355
Whitener Capital Management
North Carolina
– -$8K -100 Closed
DWM
356
Destination Wealth Management
California
– -$5K -60 Closed
SWP
357
Stratos Wealth Partners
Ohio
– -$5K -54 Closed
FCAG
358
First Capital Advisors Group
New Jersey
– -$3K -32 Closed
JWA
359
JFS Wealth Advisors
Pennsylvania
– -$2K -28 Closed
EFSCE
360
Enterprise Financial Services Corp (EFSC)
Missouri
– -$1K -12 Closed
11 12 13 14
15

WST Hedge Fund Activity: Q2 2018 in Review

324 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q2 2018, worth a combined $6.86B — up 10% from $6.23B a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new WST positions and 36 closed out — a net gain of 3 holders — while 102 added to existing stakes and 118 trimmed.

The largest buyer was Bessemer Group, adding an estimated $86.9M. The largest seller was Select Equity Group, cutting an estimated $149M.

  • 324 institutional investors held West Pharmaceutical (WST) as of Q2 2018, up from 323 in Q1 2018.
  • Funds reported $6.86B of West Pharmaceutical stock for Q2 2018, up 10% quarter-over-quarter.
  • 39 funds opened new West Pharmaceutical positions in Q2 2018 and 36 closed out, a net change of +3 holders.
  • The largest West Pharmaceutical buyer in Q2 2018 was Bessemer Group, an estimated $86.9M added.
  • The largest West Pharmaceutical seller in Q2 2018 was Select Equity Group, an estimated $149M sold.

Based on aggregated 13F filings for Q2 2018.